Authors

G.H. Giudice, A.H.L. Machado, M.P. Souza, L.N.B. Caldas, M.L. Vieira, E.D. Botelho,

J.C.L. Ambrósio, J.J Zacca, National Health Surveillance Agency (Anvisa) and Chemistry Institute, University of Brasília.

First author bio

Gabriella Giudice holds a Bachelor degree in Chemistry and a Master degree in analytical chemistry from the University of Brasília, Brazil. Currently works at the Controlled Substances Office at Brazilian Health Regulatory Agency (Anvisa). The Office is responsible for chemically analyzing and scheduling substances, such as NPS, in Brazil.

Authors

P.L. Hill, K.J. Siefried, S. Tzanetis, A. Peacock, S. Lenton, N. Ezard, National Centre for Clinical Research on Emerging Drugs, Australia.

First author bio

Penny is the Prompt Response Network Lead and Emerging Drugs Research Fellow at NCCRED. She has a background in the community health and harm reduction sectors, working and volunteering in needle syringe programs, primary health care facilities and drug checking services in Australia and internationally. She recently completed her PhD with the Burnet Institute, investigating opioid overdose. She is a current board member of Harm Reduction Victoria, Harm Reduction Australia, the Vienna NGO Committee on Drugs, the International Drug Policy Consortium’s Members Advisory Council, and is the co-founder of Students for Sensible Drug Policy Australia.

Email address: penny.hill@unsw.edu.edu

Authors

A. S. Tavares, E. Carolino, A. Rosado, L. Calmeiro, and S. Serpa.

First author bio

Ana Sofia Tavares is a Professor at the Department of Diagnostic, Therapeutic and Public Health Sciences and an integrated researcher at H&TRC ‚Äì Health and Technology Research Center of Lisbon School of Health Technology (ESTeSL), Polytechnic Institute of Lisbon, Portugal. Before this, she was responsible for the EPO implementation and detection at the Doping Analysis Laboratory, of the Portuguese Institute of Sport and Youth, Portugal (2007-2015). In parallel, in 2010, she started teaching at ESTeSL where she joined as an invited adjunct professor, dedicating herself exclusively to teaching in September 2015 to the present date. She is responsible for the teaching of several curricular units in the degree in Biomedical Laboratory Sciences, responsible for the valency of internships, and teaching in the master in Clinical Laboratory Technologies. She is also a supervisor of research work in the scope of the undergraduate and master’s degree and collaborates with the scientific activity in the area of Clinical Analysis and Public Health. She finished her PhD dissertation in 2019, supervised by Professor Sid√≥nio Serpa and Luis Horta, concerning the use of PES in recreational athletes- gym settings and proximal determinants that justify such practices. As main research interests, the areas of Clinical Chemistry, Doping, Behaviors and additions with direct impact in terms of Public Health stand out, highlighting the investigation of attitudes and motivations that lead the individual to consume performance-enhancing substances or doping substances in the practice of physical activity / sport and assessment of the physiological impact of taking these substances in biochemical terms. She integrates several national and international funded projects, and holds several publications as author and co-author, published in indexed journals with an impact factor – national and international, collaborating as a reviewer in several indexed journals of international circulation.Penny is the Prompt Response Network Lead and Emerging Drugs Research Fellow at NCCRED. She has a background in the community health and harm reduction sectors, working and volunteering in needle syringe programs, primary health care facilities and drug checking services in Australia and internationally. She recently completed her PhD with the Burnet Institute, investigating opioid overdose. She is a current board member of Harm Reduction Victoria, Harm Reduction Australia, the Vienna NGO Committee on Drugs, the International Drug Policy Consortium‚Äôs Members Advisory Council, and is the co-founder of Students for Sensible Drug Policy Australia

Authors

G Planchuelo, A Gallegos, M Evans-Brown, R Christie, R Jorge, J De Morais, R Sedefov

First author bio

Greg Planchuelo is a Spanish national working as database management development officer in the action on new drugs sector of the EMCDDA. He is responsible for managing information on New Psychoactive Substances reported from Member States via the European Database on New Drugs. Greg holds a PhD in biology from the Technical University of Berlin.

Authors

G Planchuelo, A Gallegos, M Evans-Brown, R Christie, R Jorge, J De Morais, R Sedefov

First author bio

Greg Planchuelo is a Spanish national working as database management development officer in the action on new drugs sector of the EMCDDA. He is responsible for managing information on New Psychoactive Substances reported from Member States via the European Database on New Drugs. Greg holds a PhD in biology from the Technical University of Berlin.

Authors

D.M. Papsun, A.J. Krotulski, B.K. Logan

First author bio

Donna Papsun is a forensic toxicologist at NMS Labs in Willow Grove, PA. She has dual Bachelor of Science degrees from West Virginia University in Chemistry and Forensic & Investigative Science and a Master of Science degree in Pharmacology from Thomas Jefferson University. She is also certified as a Diplomate in Forensic Toxicology through the American Board of Forensic Toxicology and is a member of both the Society of Forensic Toxicologists (SOFT) and the American Academy of Forensic Sciences (AAFS).

Ms. Papsun has been with NMS Labs since 2008 and began employment in the laboratory as a bench analyst, before being promoted to a toxicologist in 2012. Ms. Papsun’s main area of interest is NPS (novel psychoactive substances). As one of the two leaders of NMS’s NPS strategy team, she continuously works to help maintain NMS’s leadership in identifying the newest trends in the changing landscape of the designer drug market and developing tests for their detection in forensic toxicology casework.

Authors

E. Erin Artigiani (Eric D. Wish)

First author bio

Erin Artigiani received her Master’s Degree in Sociology from the University of California, Los Angeles, and a Bachelor’s Degree in Sociology & Psychology from Wellesley College. She is Deputy Director for Policy at the University of Maryland’s Center for Substance Abuse Research (CESAR) where she has worked since 1997. Ms. Artigiani has 25 years of experience in substance abuse research and policy development. She is currently Co-Investigator on the ONDCP-funded Emergency Department Drug Surveillance (EDDS; https://cesar.umd.edu/landing/EDDS) project and the OOCC-funded Maryland EDDS project and is Project Director for the DOL-funded WORC internship program in Western Maryland. She collaborated on the Maryland Rural Opioid Technical Assistance project as Project Co-Director. For 6 years she was Co-Investigator for the National Drug Early Warning System (NDEWS) funded by the NIH’s National Institute on Drug Abuse (NIDA). She managed all daily activities for NDEWS, a public health surveillance system developed by CESAR and NIDA, including preparing project reports, developing studies, managing contracts and subawards, and organizing and facilitating project meetings. For 14 years, she and the Director of CESAR represented Maryland and Washington, DC, on NIDA’s predecessor to NDEWS, the national Community Epidemiology Workgroup (CEWG). She has also managed a number of epidemiological workgroups and prevention strategy evaluations for Maryland and Washington, DC, including as a part of the SAMHSA funded Strategic Prevention Framework (SPF) and the Opioid Misuse Prevention Program (OMPP). Other former projects include serving as Co-Investigator on the Community Drug Early Warning System/Drug Early Warning Signals project, working with Bowie State University as an evaluator for their substance abuse and HIV prevention strategies, and working closely with the HIDTA programs across the U.S. on the development of the Performance Measurement Program and the national annual reports.

Authors

M. M. Vandeputte, N. Verougstraete, D. Walther, G. C. Glatfelter, J. Malfliet, M. H. Baumann, A. G. Verstraete, C. P. Stove

First author bio

Marthe Vandeputte obtained her Master’s in Drug Development from Ghent University in 2019. Later that year, she started a PhD at the Laboratory of Toxicology headed by professor Christophe Stove. Her research focuses on the activity-based detection and characterization of new psychoactive substances, with a special focus on synthetic opioids.

Authors

L.K. Janssens, C.P. Stove

First author bio

Liesl Janssens (°1996) graduated in June 2019 as Master of Science in Drug Development at Ghent University. In September 2019 she started her PhD at the Laboratory of Toxicology, Faculty of Pharmaceutical Sciences, Ghent University, under the promotorship of prof. C Stove. Her research focuses on the development and application of bioassays for activity-based monitoring of doping substances and synthetic cannabinoid receptor agonists.

Authors

L.A. Smit-Rigter, L. Stegemann, D. van der Gouwe

First author bio

Laura Smit-Rigter is the national coordinator of the Drugs Information and Monitoring System (DIMS) which is part of the Drug Monitoring & Policy programme of the Trimbos Institute. She holds a PhD in neuroscience. She mainly focuses on the monitoring of trends and developments in the illicit drug market using multiple monitoring instruments. She is in particular interested in trends and developments in relation to New Psychoactive Substances (NPS). She is also a member of the Coordination point Assessment and Monitoring new drugs (CAM) of the Netherlands.

Authors

N. Anda, L. Stiles, C. Trueman, J. Vermeulen, B. Macdonald

First author bio

Nick Anda has been an analyst with Drug Information and Alert Aotearoa New Zealand since its formation in 2020. Nick’s chief responsibilities lie with the administration of High Alert – New Zealand’s drug early warning system. This role has seen Nick form relationships with key components of the Drug Early Warning system including forensic and toxicological laboratories, Police, Customs, drug checking organisations and drug treatment providers to enhance the collective understanding of the NPS landscape and reduce harm in New Zealand.

Authors

M.D. Deventer, K. Van Uytfanghe, I.M.J. Vinckier, F. Reniero, C. Guillou, C.P. Stove

First author bio

Marie Deventer is a PhD student in the Laboratory of Toxicology at Ghent University and is currently working on characterization of NPS and on the development of novel strategies to detect and characterize these substances.

Authors

Paletta S, Negri A, Bonfanti A, Cataldo A, Grasso F, Calento A, Cerveri G, Varango C

First author bio

Specialized in Psychiatry at the University of Milan, Italy. I work in psychiatric ward of Lodi Hospital (Italy), where I deal with integrated management of acute mental states and psychiatric emergencies. Specialization in psychodynamic psychotherapy of adolescents and young adults. Author of publications in the scientific field. I collaborate in scientific research activities in the pharmacological field, mainly dealing with pharmacokinetic studies and with use of long acting therapy in psychiatric disorders.